West Bengal Confirms Nipah Virus Cases

The West Bengal government has recently confirmed cases of Nipah virus infection in the state, raising public health concerns due to the virus’s high fatality rate and potential for human-to-human transmission.

About Nipah Virus

Nipah virus (NiV) is a zoonotic disease, meaning it is transmitted to humans from animals. It can also spread through contaminated food or direct person-to-person contact. The infection can range from asymptomatic cases to acute respiratory illness and fatal encephalitis.

Impact on Humans and Animals

• In humans, Nipah virus can cause fever, headache, respiratory distress, altered consciousness, and encephalitis.
• The virus also affects animals, particularly pigs, leading to severe illness and significant economic losses for farmers.

History of Outbreaks

Nipah virus was first identified in 1999 in Malaysia, during an outbreak among pig farmers. Transmission occurred due to unprotected contact with secretions or tissues of infected pigs.

Subsequent outbreaks in Bangladesh and India were linked to the consumption of raw date palm juice or fruits contaminated with urine or saliva of infected fruit bats.

Mode of Transmission

• Animal-to-human transmission through infected pigs or contaminated food
• Human-to-human transmission through close contact
• Foodborne transmission via fruits or fruit products contaminated by bats

Natural Reservoir

Fruit bats of the family Pteropodidae, especially those belonging to the Pteropus genus, are the natural hosts of the Nipah virus. These bats do not show signs of illness, but they can shed the virus. Evidence of Nipah virus has been found in bat populations across several countries, indicating a potential risk of spread to new regions.

Treatment and Prevention

Currently, there are no specific drugs or vaccines available for Nipah virus infection. Management is primarily supportive, focusing on intensive care. Due to its epidemic potential, Nipah virus has been listed by the World Health Organization (WHO) as a priority disease under the WHO Research and Development Blueprint.